2013Journal of psychiatryRequires access

A control study of fluvoxamine and clomipramine in the treatment of adolescents with OCD

HU Fudon

Open publisher page 0 citations

Abstract

Objective To study the efficacy and adverse reactions of fluvoxamine and clomipramine in the treatment of adolescents with OCD.Methods 42 adolescents with OCD were randomized into fluvoxamine group(21 cases) and clomipramine group(21 cases) treated with fluvoxamine and clomipramine respectively for 8 weeks.All patients were assessed with Yale-Brown Obsessive Compulsive Scale(Y-BOCS) and Hamilton Anxiety Scale(HAMA) to evaluate the efficiency and were assessed with Treatment Emergent Symptom Scale(TESS) to evaluate the side effects.Results There was no significant difference in response rate between fluvoxamine group and clomipramine group(86.4% vs.86.4%,P = 1.00).Compared with the baseline,scores of Y-BOCS and HAMA in both groups decreased significantly at the 4th,8th week of the treatment(P 0.01).The rate of adverse reactions in fluvoxamine group was significantly lower than that in clomipramine group(35% vs.70%,P 0.05).Conclusion Fluvoxamine is safe and effective in the treatment of adolescents with OCD.

About this research paper

What this paper is about

Objective To study the efficacy and adverse reactions of fluvoxamine and clomipramine in the treatment of adolescents with OCD.Methods 42 adolescents with OCD were randomized into fluvoxamine group(21 cases) and clomipramine group(21 cases) treated with fluvoxamine and clomipramine respectively for 8 weeks.All patients were assessed with Yale-Brown Obsessive Compulsive Scale(Y-BOCS) and Hamilton Anxiety Scale(HAMA) to evaluate the efficiency and were assessed with Treatment Emergent Symptom Scale(TESS) to evaluate the side effects.Results There was no significant difference in response rate between fluvoxamine group and clomipramine group(86.4% vs.86.4%,P = 1.00).Compared with the baseline,scores of Y-BOCS and HAMA in both groups decreased significantly at the 4th,8th week of the treatment(P 0.01).The rate of adverse reactions in fluvoxamine group was significantly lower than that in clomipramine group(35% vs.70%,P 0.05).Conclusion Fluvoxamine is safe and effective in the treatment of adolescents with OCD.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the efficacy and adverse reactions of fluvoxamine and clomipramine in the treatment of adolescents with OCD.Methods 42 adolescents with OCD were randomized into fluvoxamine group(21 cases) and clomipramine group(21 cases) treated with fluvoxamine and clomipramine respectively for 8 weeks.All patients were assessed with Yale-Brown Obsessive Compulsive Scale(Y-BOCS) and Hamilton Anxiety Scale(HAMA) to evaluate the efficiency and were assessed with Treatment Emergent Symptom Scale(TESS) to evaluate the side effects.Results There was no significant difference in response rate between fluvoxamine group and clomipramine group(86.4% vs.86.4%,P = 1.00).Compared with the baseline,scores of Y-BOCS and HAMA in both groups decreased significantly at the 4th,8th week of the treatment(P 0.01).The rate of adverse reactions in fluvoxamine group was significantly lower than that in clomipramine group(35% vs.70%,P 0.05).Conclusion Fluvoxamine is safe and effective in the treatment of adolescents with OCD.

Key concepts: Clomipramine, Fluvoxamine, Psychology, Adverse effect, Internal medicine, Anesthesia, Medicine, Psychiatry

Related papers

Back to paper searchBrowse research topicsOriginal source
A control study of fluvoxamine and clomipramine in the treatment of adolescents with OCD — Research Paper | ScholarLens